【20231216~20231222】
Quick Facts of the Week:
This week, there were 2 investment and financing cases in the domestic digital medical industry, including Internet medical management platforms, human soft tissue biomechanical imaging equipment, etc.
Corporate events: 1 Yidu Technology released its self-developed medical model and signed a cooperation agreement with Huawei.
2 Biotech company Owkin enters into a collaboration agreement with Merck to develop AI-driven cancer diagnostics
Technological innovations:1 Researchers at Stanford and the University of Toronto: Smartphones and speakers may be able to detect alcohol poisoning by analyzing speech patterns.
2 Leeds pilots remote monitoring tools to support people with long-term conditions.
oneFinancing mergers and acquisitions
1 Internet medical management platform: The medical service platform for going to Japan has completed a 20 million Series A financing to improve the accessibility of Japan's high-quality medical care in overseas markets
Recently, the medical service platform to Japan has completed a round of financing, led by ANRI, with a total financing amount of about 20 million yuan. The proceeds will be used to strengthen recruitment efforts and attract top talent. Through this initiative, Chem Vanguard will further expand into the Chinese market in the future and support the health of many Chinese patients with high-quality medical services from Japan. In addition, the company also plans to actively take various measures to improve the quality and user satisfaction of cross-border medical services. At present, "Connecting Kangwanjia" has built an Internet medical management platform to launch a comprehensive health consulting service for Chinese patients for critical and chronic diseases, covering prevention, diagnosis and development.
arterial net).2. Human soft tissue biomechanical imaging equipmentXijian Technology completed tens of millions of yuan in Pre-A+ round of financing for product research and development, team expansion and marketing
Recently, Beijing Xijian Technology announced the completion of tens of millions of yuan in Pre-A+ round of financing, this round of financing led by Yizhuang Capital, followed by Ruihua Capital, the old shareholder Yuanhui Chuangyi continued to make additional investment, and Index Capital served as the exclusive financial advisor. The funds from this round of financing will be used for product research and development, team expansion and marketing. Only two years after its establishment, Xijian Technology has completed three rounds of financing. The company focuses on the blue ocean rigid demand market in the health field such as sports, medical beauty, and diagnosis and treatment of major diseases, and provides the industry with world-leading biomechanical imaging equipment for human soft tissues (such as skeletal muscle, ** tumors, blood vessels, nuclear cardiac organs, etc.), and jointly builds an intervention ecosystem based on human biomechanical imaging.
arterial net).
II. II. IICorporate events
1. Medical model: Yidu Technology released its self-developed medical model and signed a cooperation agreement with Huawei
On December 21, 2023, the "2023 Medical Intelligence Conference" hosted by Yidu Technology and co-organized by Huawei Technologies (hereinafter referred to as "Huawei") was held in Beijing. With the theme of "Mapping Healthcare Wisely, Transcending the Future", the conference explored the opportunities and changes brought by new technologies such as artificial intelligence to the medical industry. At the meeting, the medical vertical domain model independently developed by Yidu Technology was officially released, which is the first professional large language model for multiple scenarios in the medical vertical field in China, and Yidu Technology's medical scenario solution has also ushered in a comprehensive upgrade. At the same time, Yidu Technology and Huawei signed a deepening cooperation agreement at the meeting and jointly launched smart medical solutions to accelerate the intelligent transformation of the healthcare industry.
arterial net).2 AI Cancer Diagnosis: Biotech company Owkin has entered into a collaboration agreement with Merck & Co., Ltd. to develop AI-driven cancer diagnostics technology
On December 19, 2023, Owkin, a biotechnology company applying artificial intelligence (AI) to drug discovery, development, and diagnostics, announced that it has entered into a collaboration agreement with Merck & Co., Ltd. to develop and commercialize AI-driven digital pathology diagnostic technology for the EU market. This collaboration aims to develop a pre-screening procedure to improve the detection rate of MSI-H in endometrial, gastric, small bowel and biliary tract cancers. Among these cancer types, the incidence of MSI-H is low, and MSI-H screening is not routinely performed. Cooperation will initially focus on the European Union.
Arterial network) III. Technological innovation
1 Smart Alcohol Poisoning Detection: Researchers at Stanford and the University of Toronto: Smartphones and speakers may be able to detect alcohol poisoning by analyzing voice patterns
U.S. researchers have learned that sensors in smartphones and smart speakers can help determine the extent of a person's alcoholism based on changes in their voice. Researchers from Stanford University School of Medicine and the University of Toronto conducted a small study of 18 adults aged 21 and older. Participants were given weight-based alcohol doses and randomly assigned a series of tongue twisters – one before drinking and one every hour for seven hours after drinking. Participants were asked to read tongue twisters aloud and place their smartphones on a one- to two-foot table to record their voices. The scientists also measured their breath alcohol concentration at the beginning of the study and every 30 minutes for up to 7 hours. They use digital programs to isolate the speaker's voice, break it down into one-second increments, and analyze metrics such as frequency and pitch. When examined against breath alcohol test results, changes in participants' voice patterns can lead to alcoholism as the experiment progresses, with up to 98% accuracy.
health tech world）
2 Digital surveillance: Leeds pilots remote monitoring tools to support people with long-term conditions
Leeds has launched a trial of remote monitoring technology to see how it can support older people to live in their own homes and reduce the number of visits to a doctor or hospital. Integrated digital services spanning NHS West Yorkshire ICB and Leeds City Council, have joined forces with Luscii to pilot their healthcare products to help older adults manage their health conditions. By using the Luscii solution, individuals with conditions such as chronic obstructive pulmonary disease and diabetes can simply track their condition at home in the hope that this will improve their health.
health tech world）